Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05926_nanopub.RA6NYUzgA9nEGqhmQSQLCQVr2KvbNxheEuvWIJkBIKVYM#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05926 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05926 label "Actyve hormone therapy [drugbank:DB05926]" assertion.
- drugbank:DB05926 seeAlso DB05926 assertion.
- drugbank:DB05926 description "Actyve hormone therapy employs Vyteris' proprietary Actyve(TM) transdermal drug delivery technology, which is positioned to provide a safe and effective method of delivering drugs via a pre-programmed regulating system that mimics the body's natural rhythms, a characteristic important in the delivery of therapeutics for the treatment of infertility. The Company's Actyve(TM) transdermal technology uses an integrated circuit to control a small amount of current that delivers drugs through the skin. This process is called iontophoresis. The two-component system employs a transdermal patch containing the drug and a small battery-powered controller that precisely controls the rate and amount of drug released from the patch. The level of control is intended to mimic IV or infusion pump delivery without needles." assertion.
- drugbank:DB05926 identifier "drugbank:DB05926" assertion.
- drugbank:DB05926 title "Actyve hormone therapy" assertion.
- drugbank:DB05926 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05926 drugbank_vocabulary:drugbank-id "DB05926" assertion.
- drugbank:DB05926 bio2rdf_vocabulary:x-identifiers.org DB05926 assertion.
- drugbank:DB05926 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05926" assertion.
- drugbank:DB05926 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05926 bio2rdf_vocabulary:identifier "DB05926" assertion.